Rare Neurological Disease Treatment Market to Reach USD 43.7 Billion by 2036 as Orphan Drug Approvals and Genetic Diagnostics Expand Specialist Care | Future Market Insights

NEWARK, Del., June 25, 2026 /PRNewswire/ — According to a recent study by Future Market Insights (FMI), the global Rare Neurological Disease Treatment Market is entering a high-value growth phase, driven by accelerated orphan drug approvals, expanding genomic…

Read the full release →

News provided by PR Newswire.